A Phase 3 Randomized, Multicenter Study of Subcutaneous Daratumumab Versus Active Monitoring in Subjects with High-risk Smoldering Multiple Myeloma

  • Jana, Bagi, (PI)

    Project: Other project

    StatusActive
    Effective start/end date9/5/186/16/26